This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

BTIG Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Tipranks - Tipranks - Wed Jun 24, 4:52PM CDT

BTIG analyst Ryan Zimmerman maintained a Buy rating on Intuitive Surgical yesterday and set a price target of $574.00. The company’s shares closed today at $402.95.

TipRanks' Prime Week Sale - 70% Off

According to TipRanks, Zimmerman is a 2-star analyst with an average return of 0.7% and a 42.31% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Solventum Corporation, and Intuitive Surgical.

Intuitive Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $561.33, which is a 39.31% upside from current levels. In a report released on June 15, Goldman Sachs also reiterated a Buy rating on the stock with a $558.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on Intuitive Surgical’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.77 billion and a net profit of $821.5 million. In comparison, last year the company earned a revenue of $2.25 billion and had a net profit of $698.4 million

Read More on ISRG:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).